Prenatal nicotine exposure in rhesus monkeys compromises development of brainstem and cardiac monoamine pathways involved in perinatal adaptation and sudden infant death syndrome: Amelioration by Vitamin C

Neurotoxicology and Teratology

Volumn 33, Issue 3, 2011, Pages 431-434

  Slotkin, Theodore A ^a   Seidler, Frederic J ^a   Spindel, Eliot R ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Brainstem; Nicotine; Norepinephrine; Oxidative stress; Serotonin; Sudden Infant Death Syndrome; Vitamin C

Indexed keywords

ASCORBIC ACID; BRAIN MONOAMINE; NICOTINE; NORADRENALIN; SEROTONIN; SEROTONIN RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CESAREAN SECTION; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HYPOXIA; MALE; NEUROCHEMISTRY; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RHESUS MONKEY; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; SIGNAL TRANSDUCTION; SUDDEN INFANT DEATH SYNDROME; SYMPATHETIC INNERVATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BIOGENIC MONOAMINES; BRAIN STEM; DISEASE MODELS, ANIMAL; FEMALE; FETAL DEVELOPMENT; FETAL HEART; FETAL HYPOXIA; HUMANS; INFANT, NEWBORN; MACACA MULATTA; NICOTINE; OXIDATIVE STRESS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN; SMOKING; SUDDEN INFANT DEATH;

MACACA MULATTA; PRIMATES; RODENTIA;

EID: 79957805367     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2011.02.001     Document Type: Article

References (41)

1. Adgent M.A. Environmental tobacco smoke and sudden infant death syndrome: a review. Birth Defects Res B 2006, 77:69-85.
2. Aycicek A., Ipek A. Maternal active or passive smoking causes oxidative stress in cord blood. Eur J Pediatr 2008, 167:81-85.
3. Baruteau A.E., Baruteau J., Joomye R., Martins R., Treguer F., Baruteau R., et al. Role of congenital long-QT syndrome in unexplained sudden infant death: proposal for an electrocardiographic screening in relatives. Eur J Pediatr 2009, 168:771-777.
4. Blood-Siegfried J., Rende E.K. The long-term effects of prenatal nicotine exposure on neurologic development. J Midwifery Womens Health 2010, 55:143-152.
5. Bruin J.E., Petre M.A., Lehman M.A., Raha S., Gerstein H.C., Morrison K.M., et al. Maternal nicotine exposure increases oxidative stress in the offspring. Free Radic Biol Med 2008, 44:1919-1925.
6. Bruin J.E., Gerstein H.C., Holloway A.C. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci 2010, 116:364-374.
7. DiFranza J.R., Lew R.A. Effect of maternal cigarette smoking on pregnancy complications and Sudden Infant Death Syndrome. J Fam Pract 1995, 40:385-394.
8. DiFranza J.R., Aligne C.A., Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 2004, 113:1007-1015.
9. Duncan J.R., Garland M., Myers M.M., Fifer W.P., Yang M., Kinney H.C., et al. Prenatal nicotine-exposure alters fetal autonomic activity and medullary neurotransmitter receptors: implications for sudden infant death syndrome. J Appl Physiol 2009, 107:1579-1590.
10. Fayol L., Gulian J.M., Dalmasso C., Calaf R., Simeoni U., Millet V. Antioxidant status of neonates exposed in utero to tobacco smoke. Biol Neonate 2005, 87:121-126.
11. Fifer W.P., Fingers S.T., Youngman M., Gomez-Gribben E., Myers M.M. Effects of alcohol and smoking during pregnancy on infant autonomic control. Dev Psychobiol 2009, 51:234-242.
12. Fleming P., Blair P.S. Sudden Infant Death Syndrome and parental smoking. Early Hum Dev 2007, 83:721-725.
13. Franco P., Szliwowski H., Dramaix M., Kahn A. Decreased autonomic responses to obstructive sleep events in future victims of sudden infant death syndrome. Pediatr Res 1999, 46:33-39.
14. Gootman P.M., Gootman N., Sica A.L. A neuro-cardiac theory for Sudden Infant Death Syndrome: role of the autonomic nervous system. J Sudden Infant Death Infant Mort 1996, 1:169-182.
15. Gunes T., Koklu E., Gunes I., Narin F., Koklu S., Koklu S. Influence of maternal nicotine exposure on neonatal rat oxidant-antioxidant system and effect of ascorbic acid supplementation. Hum Exp Toxicol 2008, 27:781-786.
16. Habek D., Habek J.C., Ivanisevic M., Djelmis J. Fetal tobacco syndrome and perinatal outcome. Fetal Diagn Ther 2002, 17:367-371.
17. Halima B.A., Sarra K., Kais R., Salwa E., Najoua G. Indicators of oxidative stress in weanling and pubertal rats following exposure to nicotine via milk. Hum Exp Toxicol 2010, 29:489-496.
18. Kinney H.C. Brainstem mechanisms underlying the sudden infant death syndrome: evidence from human pathologic studies. Dev Psychobiol 2009, 51:223-233.
19. Lagercrantz H., Slotkin T.A. The "stress" of being born. Sci Am 1986, 254:100-107. [April].
20. Maritz G.S. Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring. Ther Adv Respir Dis 2009, 3:193-210.
21. Mitchell E.A., Milerad J. Smoking and the sudden infant death syndrome. Rev Environ Health 2006, 21:81-103.
22. Navarro H.A., Mills E., Seidler F.J., Baker F.E., Lappi S.E., Tayyeb M.I., et al. Prenatal nicotine exposure impairs β-adrenergic function: persistent chronotropic subsensitivity despite recovery from deficits in receptor binding. Brain Res Bull 1990, 25:233-237.
23. Ogburn P.L., Hurt R.D., Croghan I.T., Schroeder D.R., Ramin K.D., Offord K.P., et al. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol 1999, 181:736-743.
24. Oncken C.A., Hardardottir H., Hatsukami D.K., Lupo V.R., Rodis J.F., Smeltzer J.S. Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics. Obstet Gynecol 1997, 90:569-574.
25. Orhon F.S., Ulukol B., Kahya D., Cengiz B., Baskan S., Tezcan S. The influence of maternal smoking on maternal and newborn oxidant and antioxidant status. Eur J Pediatr 2009, 168:975-981.
26. Pauly J.R., Slotkin T.A. Maternal tobacco smoking, nicotine replacement and neurobehavioural development. Acta Paediatr 2008, 97:1331-1337.
27. Proskocil B.J., Sekhon H.S., Clark J.A., Lupo S.L., Jia Y., Hull W.M., et al. Vitamin C prevents the effects of prenatal nicotine on pulmonary function in newborn monkeys. Am J Respir Crit Care Med 2005, 171:1032-1039.
28. Rossner P., Milcova A., Libalova H., Novakova Z., Topinka J., Balascak I., et al. Biomarkers of exposure to tobacco smoke and environmental pollutants in mothers and their transplacental transfer to the foetus. Part II. Oxidative damage. Mutat Res 2009, 669:20-26.
29. Salihu H.M., Wilson R.E. Epidemiology of prenatal smoking and perinatal outcomes. Early Hum Dev 2007, 83:713-720.
30. Schleicher R.L., Carroll M.D., Ford E.S., Lacher D.A. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES). Am J Clin Nutr 2009, 90:1252-1263.
31. Schneider S., Huy C., Schutz J., Diehl K. Smoking cessation during pregnancy: a systematic literature review. Drug Alcohol Rev 2010, 81-90.
32. Sekhon H.S., Keller J.A., Benowitz N.L., Spindel E.R. Prenatal nicotine exposure alters pulmonary function in newborn rhesus monkeys. Am J Respir Crit Care Med 2001, 164:989-994.
33. Slotkin T.A. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol 2004, 198:132-151.
34. Slotkin T.A. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents?. Neurotoxicol Teratol 2008, 30:1-19.
35. Slotkin T.A., Cho H., Whitmore W.L. Effects of prenatal nicotine exposure on neuronal development: selective actions on central and peripheral catecholaminergic pathways. Brain Res Bull 1987, 18:601-611.
36. Slotkin T.A., Lappi S.E., McCook E.C., Lorber B.A., Seidler F.J. Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for Sudden Infant Death Syndrome. Brain Res Bull 1995, 38:69-75.
37. Slotkin T.A., Saleh J.L., McCook E.C., Seidler F.J. Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for Sudden Infant Death Syndrome. Teratology 1997, 55:177-184.
38. Slotkin T.A., Seidler F.J., Ali S.F. Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions. Brain Res 2000, 879:163-173.
39. Slotkin T.A., Seidler F.J., Qiao D., Aldridge J.E., Tate C.A., Cousins M.M., et al. Effects of prenatal nicotine exposure on primate brain development and attempted amelioration with supplemental choline or vitamin C: neurotransmitter receptors, cell signaling and cell development biomarkers in fetal brain regions of Rhesus monkeys. Neuropsychopharmacology 2005, 30:129-144.
40. Tong S., Ingenito S., Anderson J.E., Gootman N., Sica A.L., Gootman P.M. Development of a swine animal model for the study of sudden infant death syndrome. Lab Anim Sci 1995, 45:398-403.
41. Xu Z., Seidler F.J., Ali S.F., Slikker W., Slotkin T.A. Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res 2001, 914:166-178.